1Anglicheau D, Legendre C, Beanne P, et al. Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update [ J ]. Pharmacogenomics, 2007,8 ( 7 ) : 835-849.
2MacPhee I A, Holt D W. A. pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype [ J ]. Transplantation, 2008, 85 (2) : 163-165.
3Park J Y, Shin H K, Choi Y W, et al. Gomisin A induces Ca2 + -dependent activation of eNOS in human coronary artery endothelial cells [ J]. J Ethnopharmacol, 2009, 125 (2) :291-296.
